Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Clinical trial NCT01640301 · TERMINATED

Trial details

NCT number: NCT01640301
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Donor Hematopoietic Cell Transplant Recipient HLA-A*0201 Positive Cells Present Recurrent Acute Myeloid Leukemia

Start date: 2012-12-06
Primary completion: 2020-03-20
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.